Inozyme Pharma, Inc.
INZY
$1.26
-$0.23-15.44%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.07% | -8.94% | -13.02% | -11.90% | -2.00% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -26.99% | 10.55% | 3.28% | 12.30% | -13.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -14.38% | -7.86% | -12.25% | -11.17% | -2.29% |
|
|
|||||
| Total Current Assets | -14.38% | -7.86% | -12.25% | -11.17% | -2.29% |
| Net Property, Plant & Equipment | -18.67% | -16.46% | -14.17% | -10.96% | -8.73% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 50.85% | 0.00% | 147.27% | -84.49% | -0.05% |
| Total Assets | -14.08% | -7.93% | -12.00% | -11.90% | -2.36% |
|
|
|||||
| Total Accounts Payable | 14.48% | -37.34% | 62.83% | 85.76% | -41.87% |
| Total Accrued Expenses | 37.87% | 4.67% | 18.79% | -26.20% | 34.39% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 237.83% | 375.81% | 2.68% | 2.64% | 2.71% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 84.79% | 18.04% | 25.27% | -15.52% | 19.64% |
|
|
|||||
| Total Current Liabilities | 84.79% | 18.04% | 25.27% | -15.52% | 19.64% |
| Long-Term Debt | -25.22% | -7.21% | 0.67% | 0.59% | 39.62% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -60.86% | -37.37% | -26.73% | -20.54% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.90% | -1.17% | 5.48% | -3.75% | 32.71% |
|
|
|||||
| Common Stock & APIC | 0.50% | 2.94% | 0.61% | 0.43% | 0.40% |
| Retained Earnings | -7.50% | -7.31% | -8.74% | -8.17% | -8.15% |
| Treasury Stock & Other | -62.90% | 280.58% | 1.90% | -356.10% | 152.56% |
| Total Common Equity | -30.15% | -12.32% | -20.55% | -15.41% | -12.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -30.15% | -12.32% | -20.55% | -15.41% | -12.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -30.15% | -12.32% | -20.55% | -15.41% | -12.32% |
|
|
|||||